Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
DAWN on Nasdaq
There are no Buy or Sell transactions made by Atlas Venture Opportunity Fund II, L.P. since 12 Mar 2025
Holdings reported by Atlas Venture Opportunity Fund II, L.P. for Day One Biopharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
991,396 |
$11,589,419 |
$11.69 |
17 Jun 2022 |
Indirect |
|
|
| Common Stock |
766,667 |
$8,962,337 |
$11.69 |
17 Jun 2022 |
Direct |
|
|
Transactions reported by Atlas Venture Opportunity Fund II, L.P. for Day One Biopharmaceuticals, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.